Guru Ownership Trend
Guru Analysis for Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc (CNTA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $104.34 M.
Top institutional holders include Lee Ainslie and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $10.42 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 33.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Centessa Pharmaceuticals plc (CNTA)
Major holders include Lee Ainslie ($73.66 M), Steven Cohen ($12.21 M), Chuck Royce ($11.04 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.62 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $10.42 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited CNTA. The total reported sell value was $10.16 M.
Yes, 1 managers opened new positions in CNTA, and 1 increased their existing holdings. The total reported buy value was $20.58 M.